| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |